Meeting
2016 ASCO Annual Meeting
Genomic predictors of recurrence (R) or progression (P) in high grade T1 (HGT1) non-muscle invasive (NMI) bladder cancer.
Authors
Joaquim Bellmunt
Dana-Farber Cancer Institute, Boston, MA
Joaquim Bellmunt , Jaegil Kim , Stephanie A. Mullane , Brendan Reardon , Anna Orsola , Eliezer VanAllen , Gad Getz , David J. Kwiatkowski
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Bladder Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 4539)
DOI
10.1200/JCO.2016.34.15_suppl.4539
Abstract #
4539
Poster Bd #
161
Abstract Disclosures
Similar Posters
Poster
2014 Genitourinary Cancers Symposium
Somatic genomic alterations in urothelial cancer: Results of the Cancer Genome Atlas (TCGA) bladder cancer (BC) analysis.
First Author: Jonathan E. Rosenberg
Poster
2017 Genitourinary Cancers Symposium
Dissecting the genomic landscape of metastatic bladder cancer using circulating tumor DNA.
First Author: Werner J. Struss
Poster
2016 Genitourinary Cancers Symposium
Comprehensive characterization of 412 muscle invasive urothelial carcinomas: Final analysis of The Cancer Genome Atlas (TCGA) project.
First Author: Seth P. Lerner
Poster
2024 ASCO Genitourinary Cancers Symposium
Performance of the OncoUrine test on predicting patients who can avoid Re-TURBT and prognosis: A prospective, multicenter clinical study.
First Author: Xiao Yang